Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows 'No longer looking for participants' under enrollment and adds new sections for How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Intervention/Treatment label formatting and includes a Revision: v3.6.0 tag.
    Difference
    0.4%
    Check dated 2026-06-12T16:43:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.5, indicating a small update to the site, with no visible changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-05T12:33:40.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.4 has been added, replacing Revision: v3.5.3. This change updates the page's version metadata rather than its visible content or behavior.
    Difference
    0.1%
    Check dated 2026-05-15T05:51:39.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page’s UI/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend or display release rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:26.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:38.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:11:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.